Treatments for priapism in boys and men with sickle cell disease

Review of 3 studies (n=102) comparing stilboestrol, sildenafil and ephedrine or etilefrine to placebo, concludes that, given the high risk of bias and low participant numbers, there is a lack of evaluable evidence for the benefits and risks of these treatments.


Cochrane Database of Systematic Reviews